Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

JNK

Items 1-10 of 24

Page
per page
  1. TRi-1
    C9127 TRi-1
    Summary: A selective irreversible TXNRD1 inhibitor for redox biology research.
  2. Acenocoumarol
    C4675 Acenocoumarol
    Summary: A potent vitamin K epoxide reductase (VKOR) inhibitor and vitamin K antagonist.
      ≤0.2 mg/mL
  3. LL-Z 1640-4
    C5106 LL-Z 1640-4
     1 Citation
    Summary: A signal-specific JNK/p38 pathway and TAK 1 inhibitor
      Soluble in ethanol;Soluble in methanol;Soluble in DMSO;Soluble in dimethyl formamide
  4. PF-03394197(Oclacitinib)
    B5960 PF-03394197(Oclacitinib)
    Summary: Novel Janus kinase inhibitor
      ≥33.7 mg/mL
  5. AS601245
    B5942 AS601245
    Summary: c-Jun NH2-terminal protein kinase inhibitor
      insoluble in H2O; insoluble in EtOH; ≥14.25 mg/mL
  6. DTP3 TFA
    B4886 DTP3 TFA
    Summary: inhibitor of GADD45β/MKK7 complex
      ≥52.7 mg/mL
  7. SR 3576
    B7738 SR 3576
     1 Citation
    Target: JNK
    Summary: JNK3 inhibitor, potent and selective
      <50.15 mg/mL
  8. SU 3327
    B7444 SU 3327
    Summary: JNK inhibitor
      insoluble in ethanol; <26.13 mg/mL
  9. TCS JNK 6o
    B7321 TCS JNK 6o
    Target: JNK
    Summary: JNK inhibitor
      Soluble in DMSO
  10. Anisomycin
    B6674 Anisomycin
     7 Citation
    Target: p38|JNK|SAPK
    Summary: JNK agonist, potent and specific
      ≥26.5 mg/mL

Items 1-10 of 24

Page
per page